Merck & Co., Inc: Obesity trials
The registry lists 17 Obesity studies with Merck & Co., Inc as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 1 3Phase 2 8Phase 3 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or ObesityCompletedNCT06854952Phase 2Results posted
- Efficacy and Safety Trial to Evaluate the Effect of SCH 497079 on Weight in Obese and Overweight Participants (Study P05483)(COMPLETED)CompletedNCT00642993Phase 2Results posted
- Effects of Pioglitazone on Insulin Sensitivity in Healthy Overweight and Obese Males (MK-0000-170)CompletedNCT01115712Phase 1
- A Study That Will Evaluate Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects (MK-0000-159)(COMPLETED)CompletedNCT01055340Phase 1
- A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)CompletedNCT00914212Phase 1
- A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)CompletedNCT00533598Phase 2
- Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)CompletedNCT00533481Phase 2
- Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED)CompletedNCT00482638Phase 2
- To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)CompletedNCT00482196Phase 2
- A Weight Maintenance Study in Obese Patients (0364-012)(TERMINATED)TerminatedNCT00420589Phase 3
- An Investigational Drug Study to Assess Weight Loss in Obese and Overweight Patients (0364-037)(TERMINATED)TerminatedNCT00384605Phase 3
- An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)CompletedNCT00131430Phase 2/3
- A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)TerminatedNCT00131404Phase 3
- A Study of MK0364 in Obese Patients (0364-014)TerminatedNCT00131391Phase 3
- An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)CompletedNCT00109148Phase 2
- A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)CompletedNCT00092872Phase 3
- A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)CompletedNCT00092859Phase 3